Study of Amrubicin With or Without Herceptin in Patients With Metastatic Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Richard S Ungerleider, MD
Theradex
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
28 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
New Milford, Connecticut, United States
- Facility name not stated
Sharon, Connecticut, United States
- Facility name not stated
Torrington, Connecticut, United States
- Facility name not stated
Burnsville, Minnesota, United States
- Facility name not stated
Edina, Minnesota, United States
- Facility name not stated
Maplewood, Minnesota, United States
- Facility name not stated
Minneapolis, Minnesota, United States
- Facility name not stated
Saint Paul, Minnesota, United States
- Facility name not stated
Woodbury, Minnesota, United States
- Facility name not stated
Columbia, Missouri, United States
- Facility name not stated
Albany, New York, United States
- Facility name not stated
Amsterdam, New York, United States
- Facility name not stated
Hudson, New York, United States
- Facility name not stated
Latham, New York, United States
- Facility name not stated
Rexford, New York, United States
- Facility name not stated
Schenectady, New York, United States
- Facility name not stated
Troy, New York, United States
- Facility name not stated
Asheville, North Carolina, United States
- Facility name not stated
Dallas, Texas, United States
- Facility name not stated
Dallas, Texas, United States
- Facility name not stated
Dallas, Texas, United States
- Facility name not stated
El Paso, Texas, United States
- Facility name not stated
El Paso, Texas, United States
- Facility name not stated
Houston, Texas, United States
- Facility name not stated
Midland, Texas, United States
- Facility name not stated
Odessa, Texas, United States
- Facility name not stated
Plano, Texas, United States
- Facility name not stated
Tyler, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- —
- Primary completion
- —
- Completion
- 31 Dec 2007
- Last update posted
- 23 Sept 2008
- Registered enrollment
- 66
- Registry id
- NCT00380835
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.